Table 1 Demographics of the respondents
From: Anxiety and depression in the post-pandemic era: concerns about viral mutation and re-outbreak
| Â | Not infected | Asymptomatic carrier | Infection and symptoms |
|---|---|---|---|
(N = 265) | (N = 11) | (N = 42) | |
Gender | |||
 Male | 48 (18.1%) | 5 (45.5%) | 17 (40.5%) |
 Female | 217 (81.9%) | 6 (54.5%) | 25 (59.5%) |
Friend Infection | |||
 no | 263 (99.2%) | 9 (81.8%) | 20 (47.6%) |
 yes | 2 (0.8%) | 2 (18.2%) | 22 (52.4%) |
Isolation | |||
 no | 228 (86.0%) | 6 (54.5%) | 28 (66.7%) |
 yes | 37 (14.0%) | 5 (45.5%) | 14 (33.3%) |
GAD-7 score | |||
 Mean (SD) | 3.62 (3.83) | 3.09 (2.59) | 2.90 (4.30) |
 Median [Min, Max] | 2.00 [0, 21.0] | 3.00 [0, 7.00] | 1.00 [0, 18.0] |
GAD-7 stage | |||
 none | 175 (66.0%) | 8 (72.7%) | 33 (78.6%) |
 mild | 71 (26.8%) | 3 (27.3%) | 5 (11.9%) |
 moderate | 14 (5.3%) | 0 (0%) | 3 (7.1%) |
 severe | 5 (1.9%) | 0 (0%) | 1 (2.4%) |
PHQ-9 score | |||
 Mean (SD) | 4.71 (4.66) | 2.00 (2.90) | 4.60 (5.89) |
 Median [Min, Max] | 4.00 [0, 27.0] | 1.00 [0, 9.00] | 2.00 [0, 24.0] |
PHQ-9 stage | |||
 None | 139 (52.5%) | 9 (81.8%) | 26 (61.9%) |
 Slight | 97 (36.6%) | 2 (18.2%) | 8 (19.0%) |
 Moderate | 19 (7.2%) | 0 (0%) | 5 (11.9%) |
 Moderately Severe | 7 (2.6%) | 0 (0%) | 1 (2.4%) |
 Severe | 3 (1.1%) | 0 (0%) | 2 (4.8%) |
Group | |||
 patient | 0 (0%) | 11 (100%) | 42 (100%) |
 medical personnel | 103 (38.9%) | 0 (0%) | 0 (0%) |
 support staff | 65 (24.5%) | 0 (0%) | 0 (0%) |
 others | 97 (36.6%) | 0 (0%) | 0 (0%) |